Lobbying groups pushing priorities in year-end package and in 2025

All year, lawmakers have debated contentious policies impacting payers, including Medicare Advantage and the future of pharmacy benefit managers.

Some policy wishes and proposals, backed by some of Washington’s most influential lobbying groups, culminated in bipartisan bills. But most of this legislation has stagnated, either in a committee or a chamber of Congress. These priorities are under a cloud of uncertainty before what could be the closest election in recent memory, with each potential administration likely to tackle pressing health issues differently.